Balchem Corp. (NASDAQ:BCPC) Director Dino A. Rossi sold 16,400 shares of the company’s stock in a transaction that occurred on Friday, October 7th. The stock was sold at an average price of $78.57, for a total value of $1,288,548.00. Following the transaction, the director now owns 23,248 shares of the company’s stock, valued at $1,826,595.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Balchem Corp. (NASDAQ:BCPC) opened at 78.22 on Friday. The stock’s 50 day moving average price is $70.77 and its 200-day moving average price is $64.16. Balchem Corp. has a 52-week low of $53.11 and a 52-week high of $79.49. The company has a market capitalization of $2.47 billion, a PE ratio of 44.44 and a beta of 0.61.

Balchem Corp. (NASDAQ:BCPC) last posted its quarterly earnings data on Friday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.65 by $0.21. The firm had revenue of $138.80 million for the quarter, compared to the consensus estimate of $134.77 million. Balchem Corp. had a return on equity of 16.85% and a net margin of 10.18%. On average, analysts expect that Balchem Corp. will post $2.57 earnings per share for the current year.

Insider Buying and Selling by Quarter for Balchem Corp. (NASDAQ:BCPC)

Separately, Pivotal Research reiterated a “hold” rating and set a $65.00 price target on shares of Balchem Corp. in a report on Sunday, August 7th.

About Balchem Corp.

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products.

5 Day Chart for NASDAQ:BCPC

Receive News & Stock Ratings for Balchem Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corp. and related stocks with our FREE daily email newsletter.